EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Strategy‐Level Prodrug Synthesis

Paul J Geaneotes, Paul E Floreancig

Chemistry – A European Journal · 2025

DOI: 10.1002/chem.202501115 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Paul J Geaneotes und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania, 15260, USA. Hauptthemen laut MEDLINE: Prodrugs. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Science Foundation, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Organic synthesis uniquely provides opportunities to access molecules that serve defined purposes. Medicinal chemistry illustrates this attribute well with prodrug design, whereby a drug undergoes a late‐stage conversion to a conditionally responsive active medicinal agent (AMA), being a notable example. Prodrugs are becoming increasingly important in medicinal chemistry but common approaches to introduce biologically responsive groups are limited in the chemoselectivity and scope of available functionalization reactions. This Concept article describes strategy‐level prodrug synthesis, which is a powerful extension of classical prodrug formation that initiates sequences with the objective of introducing functionality early in a sequence to achieve greater scope, site‐selectivity, and chemoselectivity for the incorporation of the biologically responsive group. Examples of functionalization using alkyne hydroamination, Curtius reaction, and alkene metathesis are highlighted along with the use of the prodrugs for biological applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsAlkynesAlkenesChemistry, PharmaceuticalHumans

Stichwörter der Autor:innen

chemoselectivityconditional controlfunctionalizationprodrugsstrategy

Substanzen

ProdrugsAlkynesAlkenes

Autor:innen und Institutionen

  • Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania, 15260, USA.

Förderung

  • NIGMS NIH HHS
  • National Science Foundation
  • National Institute of General Medical Sciences

Zitieren

APA

Geaneotes, P. J., & Floreancig, P. E. (2025). Strategy‐Level Prodrug Synthesis. Chemistry – A European Journal. https://doi.org/10.1002/chem.202501115

Vancouver

Geaneotes PJ, Floreancig PE. Strategy‐Level Prodrug Synthesis. Chemistry – A European Journal. 2025. doi:10.1002/chem.202501115

BibTeX
@article{Geaneotes2025,
  author = {Geaneotes, Paul J and Floreancig, Paul E},
  title = {Strategy‐Level Prodrug Synthesis},
  journal = {Chemistry – A European Journal},
  year = {2025},
  doi = {10.1002/chem.202501115}
}
Kostenlos starten →